Submit Deal

LUPIN LIMITED

HQ - Mumbai

Summary

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally.

Deals Overview

Total Deals5

Valued Deals4

Total Value£ 1.06 B

Avg. Deal Size£ 264 M

Market Context

Senior Management

Vinita Gupta
CEO
ramesh Swaminathan
CFO
Shweta Munjal
Vice President and Head – Corporate Communications & Sustainability

Sort

gavis pharmaceuticals llc

HQ - United States

Pharmaceuticals

9 Mar 2016

Investment Date

100%

Stake

£ 564 M

Deal Value

menarini (five legacy brands)

HQ - India

Health Care Services

27 Sep 2023

Investment Date

100%

Stake

£ 10 M

Deal Value

lupin (manufacturing sites and selected r&d operations)

HQ - India

Pharmaceuticals

1 Nov 2023

Investment Date

100%

Stake

£ 71 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy